AbbVie’s stock is having a glow-up, climbing 16.1% in 2025, leaving the industry and S&P 500 behind in the dust. The company deftly pivoted after Humira’s fall from patent grace by betting big on ...
With concerns mounting and speculation swirling, the particulars of President Donald Trump’s much-touted “Liberation Day” ...
The S&P 500 Index ( $SPX) ( SPY) today is down -0.41%, the Dow Jones Industrials Index ( $DOWI ) ( DIA) is down -0.43%, and the Nasdaq 100 Index ( $IUXX) ( QQQ) is down -0.35%. June E-mini S&P futures ...
Zacks Investment Research on MSN18h
AbbVie Stock Rises 16% Year to Date: Time to Buy, Sell or Hold?AbbVie ABBV stock has gained 16.1% so far this year compared with an increase of 4.0% for the industry. The stock has also outperformed the sector and the S&P 500 index, as seen in the chart below.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback